Western Standard LLC Makes New $20.89 Million Investment in Avantor, Inc. $AVTR

Western Standard LLC purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 2,109,984 shares of the company’s stock, valued at approximately $20,889,000. Avantor comprises approximately 7.1% of Western Standard LLC’s portfolio, making the stock its 5th largest holding.

Several other hedge funds and other institutional investors have also modified their holdings of AVTR. Private Management Group Inc. increased its position in Avantor by 50.4% in the 4th quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock worth $28,156,000 after purchasing an additional 823,572 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in shares of Avantor by 425.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after buying an additional 450,801 shares in the last quarter. Brickwood Asset Management LLP increased its holdings in Avantor by 6,891.9% in the fourth quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock worth $36,489,000 after buying an additional 3,138,504 shares during the last quarter. Thornburg Investment Management Inc. raised its position in Avantor by 29.4% during the fourth quarter. Thornburg Investment Management Inc. now owns 576,959 shares of the company’s stock valued at $6,612,000 after acquiring an additional 131,186 shares in the last quarter. Finally, Agman Capital LLC bought a new position in Avantor during the fourth quarter valued at approximately $3,915,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Trading Up 4.8%

NYSE:AVTR opened at $13.97 on Thursday. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $15.93. The firm has a market cap of $9.45 billion, a price-to-earnings ratio of -16.63, a P/E/G ratio of 10.04 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The company’s 50 day moving average is $11.44 and its 200-day moving average is $9.59.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the prior year, the firm earned $0.24 EPS. Avantor’s quarterly revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current year.

Wall Street Analyst Weigh In

AVTR has been the subject of several recent research reports. Morgan Stanley boosted their target price on shares of Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Stifel Nicolaus upped their price objective on shares of Avantor from $8.00 to $15.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Citigroup increased their target price on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $13.00 price target on shares of Avantor in a research report on Thursday, July 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Avantor currently has a consensus rating of “Hold” and a consensus price target of $12.00.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.